LENZ Therapeutics (LENZ) Inventory Average (2022 - 2026)

LENZ Therapeutics (LENZ) has 4 years of Inventory Average data on file, last reported at $3.2 million in Q1 2026.

• On a quarterly basis, Inventory Average changed N/A year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.2 million, up 54.84% from the prior year.
• Inventory Average for Q1 2026 stood at $3.2 million, up from $1.9 million in the prior quarter.
• Over the last five years, Inventory Average for LENZ reached as high as $3.2 million in Q1 2026 and fell as low as $1.1 million in Q2 2023.
• Historically, Inventory Average has averaged $2.1 million across 4 years, with a median of $2.0 million in 2022.
• On a YoY basis, Inventory Average climbed as much as 29.71% in 2023 and fell as far as 37.33% in 2023.
• Year by year, Inventory Average stood at $2.5 million in 2022, then slumped by 57.54% to $1.1 million in 2023, then jumped by 84.82% to $1.9 million in 2025, then surged by 65.61% to $3.2 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $3.2 million in Q1 2026, $1.9 million in Q4 2025, and $1.1 million in Q2 2023.